Company Information
Industry 制造业
Company Introduction 2001年8月,于伟仕及其子于圣臣分别以货币出资498万元、102万元共同设立北京悦康,北京悦康设立时的注册资本为600万元。2001年8月,北京三乾会计师事务所出具《验资报告》,认定于伟仕、于圣臣的现金出资合计600万元已全部到位。2001年8月,北京悦康取得了北京市工商局核发的编号为110302231694的《企业法人营业执照》。2019年4月,悦康有限召开股东会并作出决议,以悦康有限26名股东作为共同发起人,以经瑞华会计师事务所(特殊普通合伙)审计的截至2018年7月31日的净资产为基准,折合为股份公司股本36,000万股,余额计入资本公积金,整体变更设立悦康药业集团股份有限公司。2020年3月,容诚会计师对本次整体变更的出资情况进行了审验,并出具了《验资报告》(容诚验字[2020]230Z0038)。2019年5月,前述26名发起人签署了《发起人协议》,并于同日召开创立大会,同意按前述方案整体变更设立股份有限公司,审议通过了公司章程及股东大会、董事会、监事会议事规则等议案,并选举了悦康股份第一届董事、监事。2019年5月,悦康股份取得了北京市工商行政管理局经济技术开发区分局换发的营业执照。 公司报告期内主营业务收入主要集中在心脑血管药物、消化系统药物、糖尿病用药以及抗感染药物等。银杏叶提取物注射液、天麻素注射液、注射用兰索拉唑、奥美拉唑肠溶胶囊、盐酸二甲双胍缓释片、注射用头孢呋辛钠、注射用头孢曲松钠对公司收入贡献占比较大或未来增长潜力较大,是公司的主要产品。
Main Business 心脑血管药物、消化系统药物、糖尿病用药以及抗感染药物等
Legal Representative 于伟仕
Top Executives
董事长:于伟仕
董事:宋更申,于飞,于鹏飞,张将,张启波
独立董事:陈可冀,王波,程华
Top 5 Shareholder
Shareholder name Nature Holding Date
阜阳京悦永顺信息咨询有限公司流通A股40.05%30/09/2024
菏泽三荣股权投资合伙企业(有限合伙)流通A股3.20%30/09/2024
菏泽峰胜股权投资合伙企业(有限合伙)流通A股2.84%30/09/2024
菏泽锦然股权投资合伙企业(有限合伙)流通A股2.84%30/09/2024
中信证券-中信银行-中信证券卓越成长两年持有期混合型集合资产管理计划流通A股2.27%30/09/2024
Company Secretary 郝孟阳
Solicitors 上海市瑛明律师事务所
Auditors 容诚会计师事务所(特殊普通合伙)
Tel No 010-67806688;010-87925985
Fax No 010-67802038;010-87925985
Website www.youcareyk.com
Email irm@youcareyk.com
Company Address
Register: 北京市北京经济技术开发区宏达中路6号
Office: 北京市北京经济技术开发区宏达中路6号
Listing Date 24/12/2020
Shares Capital
Shares Capital: 450,000,000
Total A Share: 450,000,000
Listed A Share: 450,000,000
Non-tradable A Share: 0
Other Share: 0
Total B Share: 0
Total H Share: 0
EPS(RMB)* ¥ 0.410
DPS(RMB)* ¥ 0.200
NBV Per Share(RMB)* ¥ 7.973
Market Capitalization(RMB) 7.470B
Smiley face Only Chinese content is avaliable
N
/
N
 : Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SH-HK Ex-Northbound trade (sell only)
N
/
N
 : Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
* Unadjusted Data
Information provided by: etnet
Terms and Conditions
Risk Disclosure:
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone.
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources, Nanyang Commercial Bank Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.